Discontinued — last reported Q1 '26
ResMed Trading Securities in Marketable Securities increased by 21.1% to $78.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.0%, from $65.38M to $78.47M. Over 4 years (FY 2021 to FY 2025), Trading Securities in Marketable Securities shows an upward trend with a 29.0% CAGR.
trading_securities_in_marketable_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.00M | $31.16M | $35.18M | $38.18M | $39.29M | $43.58M | $65.70M | $70.64M | $68.75M | $69.68M | $74.99M | $77.38M | $73.74M | $65.78M | $66.46M | $65.38M | $63.64M | $64.53M | $64.78M | $78.47M |
| QoQ Change | — | +35.5% | +12.9% | +8.5% | +2.9% | +10.9% | +50.7% | +7.5% | -2.7% | +1.4% | +7.6% | +3.2% | -4.7% | -10.8% | +1.0% | -1.6% | -2.7% | +1.4% | +0.4% | +21.1% |
| YoY Change | — | — | — | — | +70.8% | +39.9% | +86.7% | +85.0% | +75.0% | +59.9% | +14.1% | +9.5% | +7.3% | -5.6% | -11.4% | -15.5% | -13.7% | -1.9% | -2.5% | +20.0% |